+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Bone Morphogenetic Protein (BMP) Market 2019-2025

  • ID: 5129829
  • Report
  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now


  • Abbiotec, Inc.
  • ACROBiosystems Inc.
  • BioLegend, Inc.
  • Cellumed Co.,Ltd.
  • Creative BioMart
  • Ember Therapeutics, Inc.
  • MORE
Global Bone Morphogenetic Protein (BMP) Market Size, Share & Trends Analysis Report, By Type (rhBMP-2 and rhBMP-7), By Application (Trauma, Spinal Fusion, Reconstructive, Oral-Maxillofacial, and Others) and Forecast, 2019-2025.

The global bone morphogenetic protein (BMP) market is estimated to witness moderate growth during the forecast period. Some crucial factors leading to market growth include rising number of sports injuries and the increasing number of patients with musculoskeletal disorders. As per the Versus Arthritis, in 2017, musculoskeletal conditions including back pain and arthritis affected nearly 18.8 million people in UK. Low back and neck were the major cause of ill health across all age group individuals. Musculoskeletal conditions are also associated with a work-related injury.

For instance, as per the Health and Safety Executive (HSE), in 2018/2019, the total number of cases related to work-related musculoskeletal disorders was 498,000 in UK. Construction and agriculture, forestry and fishing have the highest rates of work-related musculoskeletal disorders in UK. The significant prevalence of musculoskeletal conditions increases the need for bone regeneration and bone healing procedures. Effective bone regeneration could transform the clinical management of bone and musculoskeletal disorders. BMPs can be used in several processes such as bone induction, bone formation, and bone regeneration. The studies found BMP as safe and effective as compared to bone grafting procedures, which in turn, is supporting the adoption of BMP for the treatment of musculoskeletal disorders.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. In 2018, North America is estimated to hold a significant share in the market owing to the rising incidences of spinal cord injuries and sports injuries in the region. As per the data published by the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the annual incidence of spinal cord injury is approximately 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year. This, in turn, has led the demand for spinal fusion procedures in which BMP is used as an alternative to bone grafting to facilitate bone growth and bone healing.

Some key players the market include Medtronic plc, Merck KGaA, Thermo Fisher Scientific Inc., Johnson & Johnson Services, Inc., and Ember Therapeutics, Inc. Medtronic plc offers INFUSE, a bone graft that enables stimulate the formation and remodeling of natural bone, and eliminates the requirement for bone harvesting from other parts of a patient’s body. It consists of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) with applications in specific indications including spine, trauma, and dental.

Research Methodology

The market study of the global BMP market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • White papers, research-papers, and news blogs
  • Company websites and their product catalog
The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global BMP Market Research and Analysis, By Type
  • Global BMP Market Research and Analysis, By Application
The Report covers:
  • Comprehensive research methodology of the global BMP market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global .
  • Insights about market determinants which are stimulating the global .
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3


  • Abbiotec, Inc.
  • ACROBiosystems Inc.
  • BioLegend, Inc.
  • Cellumed Co.,Ltd.
  • Creative BioMart
  • Ember Therapeutics, Inc.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic plc Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Merck KGaA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Thermo Fisher Scientific Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Johnson & Johnson Services Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Ember Therapeutics, Inc. Overview Financial Analysis SWOT Analysis Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global BMP Market by Type
5.1.1. Recombinant Human BMP (rhBMP)-2
5.1.2. Recombinant Human BMP (rhBMP)-7
5.2. Global BMP Market by Application
5.2.1. Trauma
5.2.2. Spinal Fusion
5.2.3. Reconstructive
5.2.4. Oral-Maxillofacial
5.2.5. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbiotec, Inc.
7.2. ACROBiosystems Inc.
7.3. American Research Products, Inc.
7.4. BioLegend, Inc.
7.5. Cellumed Co.,Ltd.
7.6. Creative BioMart
7.7. DePuy Synthes (Johnson & Johnson Services, Inc.)
7.8. Ember Therapeutics, Inc.
7.9. LifeSpanBioSciences, Inc.
7.10. Medtronic plc
7.11. Merck KGaA
7.12. OriGene Technologies, Inc.
7.13. Prospec-TanyTechnogene Ltd.
7.14. R&D Systems (Bio-Techne Co.)
7.15. Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
3 of 3
  • Abbiotec, Inc.
  • ACROBiosystems Inc.
  • American Research Products, Inc.
  • BioLegend, Inc.
  • Cellumed Co.,Ltd.
  • Creative BioMart
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Ember Therapeutics, Inc.
  • LifeSpanBioSciences, Inc.
  • Medtronic plc
  • Merck KGaA
  • OriGene Technologies, Inc.
  • Prospec-Tany Technogene Ltd.
  • R&D Systems (Bio-Techne Co.)
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown